PS-341, a proteasome inhibitor for cancer treatment.

被引：0
|
作者：
Adams, J [1 ]
机构：
[1] Millennium Pharmaceut Inc, Drug Discovery, Cambridge, MA 02139 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 222卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
157-MEDI
引用
收藏
页码：U665 / U665
页数：1
相关论文
共 50 条
  • [31] Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts
    Nawrocki, ST
    Bruns, CJ
    Harbison, MT
    Bold, RJ
    Gotsch, BS
    Abbruzzese, JL
    Elliott, P
    Adams, J
    McConkey, DJ
    [J]. MOLECULAR CANCER THERAPEUTICS, 2002, 1 (14) : 1243 - 1253
  • [32] Human somatic cell knockouts reveal determinants of sensitivity and resistance to proteasome inhibitor PS-341
    Lee, C
    Waldman, T
    [J]. CANCER BIOLOGY & THERAPY, 2003, 2 (06) : 700 - 701
  • [33] Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation
    Li, Chunyang
    Chen, Shuzhen
    Yue, Ping
    Deng, Xingming
    Lonial, Sagar
    Khuri, Fadlo R.
    Sun, Shi-Yong
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (21) : 16096 - 16104
  • [34] Proteasome inhibition by PS-341: A phase I study.
    Hamilton, A
    Eder, JP
    Pavlick, A
    Clark, JW
    Chachoua, A
    Ryan, DP
    Farrell, K
    Wasserstrom, H
    Liebes, L
    Wright, J
    Elliott, P
    Adams, J
    Muggia, F
    [J]. CLINICAL CANCER RESEARCH, 2000, 6 : 4549S - 4549S
  • [35] Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors
    Shah, MH
    Young, D
    Kindler, HL
    Webb, I
    Kleiber, B
    Wright, J
    Grever, M
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6111 - 6118
  • [36] The proteasome inhibitor PS-341 sensitizes tumor cells to TRAIL-mediated apoptosis.
    Sayers, TJ
    Brooks, A
    Seki, N
    Murphy, WJ
    Elliott, PJ
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3718S - 3718S
  • [37] Proteasome Inhibitor PS-341 Effectively Blocks Infection by the Severe Fever with Thrombocytopenia Syndrome Virus
    Sihua Liu
    Hongyun Liu
    Keke Zhang
    Xueping Li
    Yuqin Duan
    Zhiyun Wang
    Tao Wang
    [J]. Virologica Sinica, 2019, (05) : 572 - 582
  • [38] Phase I study of PS-341, a novel proteasome inhibitor, in patients with advanced malignancies.
    Papandreou, CN
    Pagliaro, L
    Millikan, R
    Daliani, D
    Herrmann, J
    Hong, Y
    Smith, M
    Adams, J
    Elliot, P
    Lightcap, E
    McCormack, T
    Pien, C
    Newman, R
    Logothetis, CJ
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 : 3730S - 3730S
  • [39] Proteasome Inhibitor PS-341 Effectively Blocks Infection by the Severe Fever with Thrombocytopenia Syndrome Virus
    Liu, Sihua
    Liu, Hongyun
    Zhang, Keke
    Li, Xueping
    Duan, Yuqin
    Wang, Zhiyun
    Wang, Tao
    [J]. VIROLOGICA SINICA, 2019, 34 (05) : 572 - 582
  • [40] Proteasome Inhibitor PS-341 Effectively Blocks Infection by the Severe Fever with Thrombocytopenia Syndrome Virus
    Sihua Liu
    Hongyun Liu
    Keke Zhang
    Xueping Li
    Yuqin Duan
    Zhiyun Wang
    Tao Wang
    [J]. Virologica Sinica, 2019, 34 (05) : 572 - 582
12345